non-small-celllungcancer相关论文
PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by
Recent studies show that intracellular accumulation of cholesterol leads to acquired resistance to gefitinib in non-smal......
Surgical Choice for Patients with Stage Ⅰ Non-Small-Cell Lung Cancer ≤ 2 cm:An Analysis from Surveil
Objective No consensus was reached on the surgical procedure for patients with stage Ⅰ non-small-cell lung cancer(NSCLC......
High dose [F-18]-fluorodeoxyglucose(FDG)PET/CT based imaged-guided intensity-modulated radiotherapy(
...
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-sma
Objective Approximately 30%of patients with non–small cell lung cancer(NSCLC)have locally advanced diseases(LA-NSCLC).A......
...
Significance of lesion HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squam
Background: HLA-G have seven isoforms which HLA-G1-G4 are membrane-bound and HLA-G5-G7 soluble.Previous studies reinforc......
Objective Lung cancer is the leading causes of cancer-related deaths globally.The most frequent histologic type of lung ......
Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lu
Background: For patients with locally advanced non-small-cell lung cancer (LA-NSCLC), the role of consolidation chemothe......
Determining the prevalence of EGFR mutations in patients with advanced non-small-cell lung cancer (a
Objective: IGNITE (a large, multinational, diagnostic, non-comparative, interventional study;NCT01788163) assessed EGFR ......
...
Objective: In this study, we investigated the incidence of radiation pneumonitis (RP) in non-small-cell lung cancer (NSC......
Oral Talactoferrinalfain advanced Non-small-cell Lung Cancer:a Meta-analysis of Randomized Controlle
Backgrounds:Until recently,immunotherapy has gained interest of oncologists.Although a growing body of evidence about ne......
Aim:Erlotinib is used to treat non-small-cell lung cancer (NSCLC), which targets epidermal growth factor receptor (EGFR)......
Postoperative radiotherapy for resected pathological stage ⅢA-N2 non-small-cell lung cancer: a retro
...
No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treat
...
Concurrent Chemoradiotherapy with Weekly Vinorelbine plus Carboplatin in Patients with Locally Advan
...
Calcium is a second messenger which is required for regulation of many cellular processes.However,excessive elevation or......
Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity a
...
Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc ge
...
Apoptosis of Lewis Lung Carcinoma Cells Induced by Microwave via p53 and Proapoptotic Proteins In vi
...
RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese advanced non-s
Objective To investigate the clinical predictive significance of ribonucleotide reductase Ml (RRM1) and breast cancer su......
目的:探讨氧化苦参碱对非小细胞肺癌(NSCLC)A549细胞及裸鼠移植瘤的抗肿瘤作用及其分子机制。方法:用CCK-8法检测氧化苦参碱对A549......
Background Lung cancer is the most common cancer worldwide and remains the leading cause of cancer-related mortality.A m......
【摘要】 目的 观察抗肿瘤国产药物长春瑞滨(盖诺)和顺铂联合化疗(NP方案)治疗晚期非小细胞肺癌的疗效。方法 采用NP方案治疗晚期......
Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal
AIM: To analyze the clinical and dosimetric predictive factors for radiation-induced esophageal injury in patients with ......
A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemothera
Objective: To evaluate the efficacy and safety of celecoxib plus platinum-doublet as first-line chemotherapy in treatmen......
Phase Ⅰ Study to Determine MTD of Docetaxel and Cisplatin with Concurrent Radiation Therapy for Stag
Objective: To evaluate the maximum tolerated dose (MTD) of docetaxel (DCT) and cisplatin (DDP) concurrently with three d......
Objective: To analyze the outcomes of patients who received TKI immediately after the first-line without progression as ......
Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients
Objective:Although superior clinical benefits of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI......
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Ch
Objective:Crizotinib has demonstrated promising efficacy in patients with anaplastic lymphoma kinase (ALK)-positive non-......
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-s
...
NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung can
Epidermal growth factor receptor-tyrosine kinase inhibitors(EGFR-TKIs)have achieved satisfactory clinical effects in the......
目的 探讨多基因蛋白表达联合检查判断早期非小细胞肺癌(NSCLC)术后化疗疗效的价值.方法 采用组织芯片与免疫组织化学技术(二步法)......
